Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2024-01-24 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about an upcoming earnings conference call following the declaration of unaudited financial results for Q3 and nine months ended December 31, 2023. It includes details about the date, time, and dial-in information for the call, as well as speakers from management. The document does not contain actual financial statements or detailed financial analysis but serves as an invitation and announcement of the earnings call event. Therefore, it is not the earnings release itself nor the transcript, but an announcement related to the earnings call. Given the definitions, this fits best under Call Transcript (CT) if it were the transcript, but since it is an invitation/announcement of the call, it is more aligned with Regulatory Filings (RNS) as a general regulatory announcement. However, since the category for announcements of earnings calls is not explicitly defined, and the document is primarily an announcement of the earnings conference call (not the transcript or the earnings release), the closest and most appropriate classification is Regulatory Filings (RNS). Confidence is high due to clear identification of the document as an earnings call invitation and no actual financial data included.
2024-01-24 English
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 ,inter alia, to consider and approve standalone and consolidated ....
Regulatory Filings Classification · 95% confidence The document is a short notice dated 24/01/2024 from Morepen Laboratories Limited addressed to stock exchanges. It informs about an upcoming Board Meeting scheduled for 31 January 2024 to consider and approve the unaudited financial results for the quarter and nine months ended 31 December 2023. The document is brief (1641 characters) and serves as an announcement of a future event rather than containing any financial data or results itself. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to disclosures about board meetings. This type of document is a regulatory announcement about a board meeting and financial results approval, not the financial report or results themselves. According to the rules, such short notices announcing board meetings and upcoming financial results should be classified as Regulatory Filings (RNS), since it is not the report itself nor a detailed management or earnings report.
2024-01-24 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled for January 31, 2024, to consider and approve the company's quarterly and nine months unaudited financial results. It is a short communication informing the stock exchanges and public about the meeting date and agenda. It does not contain any financial data or results itself, nor does it present any report. The document is a regulatory announcement about a board meeting, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Interim Report or Earnings Release. The document length is short (1641 characters), and it is clearly an announcement rather than a report or detailed presentation.
2024-01-24 English
Board Meeting — MOREPEN LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 31-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company…
Regulatory Filings
2024-01-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the intimation of loss of a share certificate. It references regulatory compliance under SEBI regulations and mentions issuance of a 'Letter of Confirmation' to the shareholder. The content is an announcement related to a specific administrative event concerning share certificates, not a financial report, earnings release, or management discussion. The document length is short (1853 characters), and it is clearly an official notification to the exchange rather than a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-19 English
Intimation of loss of share certificate
Regulatory Filings
2024-01-19 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.